D6567

DRF 2519

≥98% (HPLC), solid

• 同義詞: 5-[[4-[2-(4-Oxo-2H-1,3-benzoxazin3(4H)-yl)ethoxy]phenyl]methyl2,4-thiazolidinedione
• 經驗公式（希爾表示法）: C₂₀H₁₈N₂O₅S
• 分子量：: 398.43
• MDL號碼: MFCD06798336
• 分類程式碼代碼: 12352200
• PubChem物質ID: 24894036

屬性

• 化驗: ≥98% (HPLC)
• 形狀: solid
• 儲存條件: under inert gas
• 顏色: white
• 溶解度: DMSO: ≥10 mg/mL
• 儲存溫度: 2-8°C
• SMILES 字串: O=C1NC(=O)C(Cc2ccc(OCCN3COc4ccccc4C3=O)cc2)S1

描述

生化／生理作用

DRF-2519 is a dual PPARα/γ activator. DRF-2519 has better reduction of plasma insulin, triglyceride, and free fatty acid levels than those treated with rosiglitazone.

安全資訊

• 儲存類別代碼: 13 - Non Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable
• 個人防護裝備: Eyeshields, Gloves, type N95 (US)